title: Biochemical features of a patient with Zellweger-like syndrome with normal PTS-1 and PTS-2 peroxisomal protein import systems: a new peroxisomal disease.
abstract: The peroxisomal disorders represent a group of inherited metabolic disorders that derive from defects of peroxisomal biogenesis and/or from dysfunction of single or multiple peroxisomal enzymes. We described earlier an 8 1/2 year-old with a history of progressive developmental delay, micronodular cirrhosis, and elevated very long chain fatty acids in plasma and skin fibroblasts. These findings were felt to be compatible with both neonatal adrenoleukodystrophy (nALD) and Zellweger syndrome (ZS). This patient is now 21 years old and his clinical course, inconsistent with either nALD or ZS, led us to examine his peroxisomal status in light of a possible new peroxisomal disease. The normal levels of bile acid precursors found in this patient suggest that peroxisomal beta-oxidation is functional. The activities of dihydroxyacetone phosphate acyltransferase and oxidation of lignoceric acid and phytanic acid were 14, 17, and 15% of the control, respectively. This partial activity for oxidation and the normal levels of bile acid precursors suggests that this patient has peroxisomes containing beta-oxidation enzymes. Western blot analysis of subcellular organelles showed that beta-oxidation enzyme proteins are present at normal levels in catalase-negative peroxisomes of density equivalent to normal peroxisomes. The presence of acyl-CoA oxidase and 3-ketoacyl-CoA thiolase in catalase-negative peroxisomes suggests that both peroxisomal targeting signal-1 (PTS-1), and peroxisomal targeting signal-2 (PTS-2)-mediated protein transport processes into peroxisomes are normal in this patient. These findings of catalase-negative peroxisomes of normal density and normal PTS-1 and PTS-2 import machinery with partial peroxisomal functions clearly demonstrate that this patient differs from those with known disorders of peroxisomal biogenesis.
authors.affiliation: Pediatrics Department, Medical University of South Carolina, Charleston 29425, USA.
authors.forename: I
authors.initials: I
authors.lastname: Singh
authors.forename: R G
authors.initials: RG
authors.lastname: Voigt
authors.forename: F G
authors.initials: FG
authors.lastname: Sheikh
authors.forename: K
authors.initials: K
authors.lastname: Kremser
authors.forename: F R
authors.initials: FR
authors.lastname: Brown
mesh_terms: D002374:Catalase / Q000378:metabolism; D002478:Cells, Cultured; D002648:Child; D003576:Electron Transport Complex IV / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D008297:Male; D008830:Microbodies / Q000378:metabolism*; D009245:NADH Dehydrogenase / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D015211:Zellweger Syndrome / Q000097:blood / Q000378:metabolism* / Q000652:urine
chemical_list: D011506:Proteins; D002374:Catalase; D009245:NADH Dehydrogenase; D003576:Electron Transport Complex IV